Therapeutic Solutions International - About the company
Therapeutic Solutions International is a public company based in Oceanside (United States), founded in 2007. It operates as a Developer of immunotherapeutics for cancer and infectious diseases. Therapeutic Solutions International has raised an undisclosed amount in funding. The company has 3580 active competitors, including 1185 funded and 828 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of immunotherapeutics for cancer and infectious diseases. It offers Umbilical Cord-derived Mesenchymal Stem Cells-based therapeutics for acute respiratory distress syndrome, Covid-19, chronic traumatic encephalopathy, solid tumors, and others.
- Website
- therapeuticsolutionsint.com
Key Metrics
Founded Year
2007
Location
Oceanside, United States
Stage
Public
Latest Funding Round
Investors
Ranked
1923rd among 3580 active competitors
Annual Revenue
$0 - $1M as on Dec 31, 2023
Employee Count
5 as on Jul 31, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Therapeutic Solutions International
Therapeutic Solutions International is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Therapeutic Solutions International, Inc. CIN: 1419051 , United States, Active | Mar 02, 2011 | $0 - $1M (As on Dec 31, 2023) | 3 (As on Dec 31, 2022) | - |
Therapeutic Solutions International's IPO details
Therapeutic Solutions International got listed on Apr 24, 2009.
Click here to take a look at Therapeutic Solutions International's IPO in detail
Sign up to download Therapeutic Solutions International's company profile
Therapeutic Solutions International's funding and investors
Therapeutic Solutions International has raised funding over 4 rounds. Its first funding round was on May 04, 2015. Therapeutic Solutions International has 1 institutional investor.
Here is the list of recent funding rounds of Therapeutic Solutions International:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 02, 2018 | 5559312 | Post IPO | 1609694 | 8602041 | 1574488 | 5462148 |
Sep 19, 2016 | 3492693 | Post IPO | 6810171 | 1354519 | 7159532 | 6819987 |
Feb 05, 2016 | 5640296 | Post IPO | 5135553 | 8277316 | 6769767 | 2355507 |
Therapeutic Solutions International's founders and board of directors
Founder? Claim ProfileTherapeutic Solutions International's employee count trend
Therapeutic Solutions International has 5 employees as of Jul 26. Here is Therapeutic Solutions International's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Therapeutic Solutions International's Competitors and alternates
Top competitors of Therapeutic Solutions International include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Therapeutic Solutions International, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
2nd | BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 81/100 | |
3rd | Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 74/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 72/100 | ||
9th | Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 72/100 | |
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
1923rd | Therapeutic Solutions International 2007, Oceanside (United States), Public | Developer of immunotherapeutics for cancer and infectious diseases | - | 30/100 |
Looking for more details on Therapeutic Solutions International's competitors? Click here to see the top ones
Therapeutic Solutions International's Investments and acquisitions
Therapeutic Solutions International has made no investments or acquisitions yet.
Reports related to Therapeutic Solutions International
Here is the latest report on Therapeutic Solutions International's sector:
News related to Therapeutic Solutions International
•
Therapeutic Solutions International to Voluntarily DelistBusiness Wire•Apr 24, 2025•Therapeutic Solutions International
•
•
•
•
•
•
•
•
•
Are you a Founder ?
FAQs about Therapeutic Solutions International
Explore our recently published companies
- BIA Home Care Service - Pittsburgh based, 2021 founded, Unfunded company
- JK Auto & Truck Repair - Marlton based, Unfunded company
- Lippert - Elkhart based, 1956 founded, Unfunded company
- AMZ Tech Solutions - Cedar Rapids based, Unfunded company
- ItsGuru - Houston based, 2006 founded, Unfunded company
- Anh Totti Nguyen - Unfunded company